Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review

Background: Non-alcoholic fatty liver disease (NAFLD) is closely linked with obesity and the prevalence of NAFLD is about 17% to 33% in the Western world. There is a strong association of NAFLD with insulin resistance and, hence, insulin sensitisers have been tried. This systematic review examined t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: D Shyangdan, C Clar, N Ghouri, R Henderson, T Gurung, D Preiss, N Sattar, A Fraser, N Waugh
פורמט: Artigo
שפה:Inglês
יצא לאור: NIHR Journals Library 2011-11-01
סדרה:Health Technology Assessment
נושאים:
insulin-sensitiser
non-alcoholic-fatty-liver-disease
type-2-diabetes-mellitus
hepatic-steatosis
non-alcoholic-steatohepatitis
diagnosis
גישה מקוונת:https://doi.org/10.3310/hta15380
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים